Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
COVID-19 vaccine
List of COVID-19 vaccine authorizations
Другие языки:

List of COVID-19 vaccine authorizations

Подписчиков: 0, рейтинг: 0

For COVID-19 vaccination policy by country, see Vaccination policy § Table.

National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.

Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi–GSK. Seven others are under assessment by the WHO: Sputnik V, Sinopharm WIBP, Abdala, Zifivax, Corbevax, COVIran Barekat, and SCB-2019.

Of the 40 vaccines, 16 have a full or emergency authorization in only one country, 12 in ten or fewer countries, and 12 in more than ten countries.

Note that in some countries, vaccines may be authorized solely for travel purposes. They may not be approved for the general population. For example, the CoronaVac, Covishield, BBIBP-CorV and Covaxin vaccines are not part of Australia's national vaccination program; however, they are recognized for the purpose of travel to Australia.

Overview maps

Oxford–AstraZeneca

  Full authorization
  Emergency authorization
  Allowed for travel
  Eligible COVAX recipient
  Usage stopped

The Oxford–AstraZeneca COVID-19 vaccine, sold under the brand names Vaxzevria and Covishield, is a viral vector vaccine produced by the British University of Oxford, British-Swedish company AstraZeneca, and the Coalition for Epidemic Preparedness Innovations. Finland, Denmark, and Norway suspended the use of the Oxford–AstraZeneca vaccine due to a small number of reports of a rare blood clot disorder. Slovakia suspended its use after the death of a predisposed recipient. South Africa suspended its use because a small trial found only minimal protection against mild to moderate disease from the locally predominant Beta variant. Japan approved the vaccine for emergency use in May 2021, but did not plan to use them immediately because of rare cases of a blood clotting disorder reported overseas. Later, Japan started to use the vaccine for people aged 40 or over to mitigate the surge of the Delta variant in August. Finland ceased use of the vaccine as the last batch expired on 30 November 2021. Until then it was only offered for those aged 65 or more due to extremely rare coagulation disorders among younger recipients of the vaccine. After this Finland will not procure more of the vaccine. The AstraZeneca vaccine is the most widely accepted internationally, and the most popular in terms of total inoculated worldwide, over 1.3 billion. The AstraZeneca vaccine is administered in more countries than any other vaccine.

Full (5)
  1. Australia
  2. Brazil
  3. Canada
  4. India
  5. Israel

EMA countries

  1. Austria
  2. Belgium
  3. Bulgaria
  4. Croatia
  5. Cyprus
  6. Czech Republic
  7. Denmark
  8. Estonia
  9. Finland
  10. France
  11. Germany
  12. Greece
  13. Hungary
  14. Iceland
  15. Ireland
  16. Italy
  17. Latvia
  18. Liechtenstein
  19. Lithuania
  20. Luxembourg
  21. Malta
  22. Netherlands
  23. Norway
  24. Poland
  25. Portugal
  26. Romania
  27. Slovakia
  28. Slovenia
  29. Spain
  30. Sweden
Emergency (170)
  1. Afghanistan
  2. Albania
  3. Algeria
  4. Andorra
  5. Angola
  6. Argentina
  7. Armenia
  8. Azerbaijan
  9. Bahrain
  10. Bangladesh
  11. Benin
  12. Bhutan
  13. Bolivia
  14. Bosnia and Herzegovina
  15. Botswana
  16. Brunei
  17. Burkina Faso
  18. Cambodia
  19. Cameroon
  20. Cape Verde
  21. Central African Republic
  22. Chile
  23. Colombia
  24. Comoros
  25. Congo-Brazzaville
  26. Congo-Kinshasa
  27. Costa Rica
  28. Djibouti
  29. Dominican Republic
  30. East Timor
  31. Ecuador
  32. Egypt
  33. El Salvador
  34. Eswatini
  35. Ethiopia
  36. Fiji
  37. Gambia
  38. Georgia
  39. Ghana
  40. Guatemala
  41. Guinea-Bissau
  42. Guinea
  43. Honduras
  44. Indonesia
  45. Iran
  46. Iraq
  47. Ivory Coast
  48. Japan
  49. Jordan
  50. Kenya
  51. Kiribati
  52. Kosovo
  53. Kuwait
  54. Kyrgyzstan
  55. Laos
  56. Lebanon
  57. Lesotho
  58. Liberia
  59. Libya
  60. Madagascar
  61. Malawi
  62. Malaysia
  63. Maldives
  64. Mali
  65. Mauritania
  66. Mauritius
  67. Mexico
  68. Micronesia
  69. Moldova
  70. Mongolia
  71. Montenegro
  72. Morocco
  73. Mozambique
  74. Myanmar
  75. Namibia
  76. Nauru
  77. Nepal
  78. New Zealand
  79. Nicaragua
  80. Niger
  81. Nigeria
  82. North Macedonia
  83. Oman
  84. Pakistan
  85. Palestine
  86. Panama
  87. Papua New Guinea
  88. Paraguay
  89. Peru
  90. Philippines
  91. Qatar
  92. Rwanda
  93. Samoa
  94. São Tomé and Príncipe
  95. Saudi Arabia
  96. Senegal
  97. Serbia
  98. Seychelles
  99. Sierra Leone
  100. Singapore(restricted)
  101. Solomon Islands
  102. Somalia
  103. South Korea
  104. South Sudan
  105. Sri Lanka
  106. Sudan
  107. Syria
  108. Taiwan
  109. Tajikistan
  110. Thailand
  111. Togo
  112. Tonga
  113. Tunisia
  114. Turkmenistan
  115. Tuvalu
  116. Uganda
  117. Ukraine
  118. United Arab Emirates
  119. United Kingdom
  120. Uruguay
  121. Uzbekistan
  122. Vanuatu
  123. Vietnam
  124. Yemen
  125. Zambia
  126. Zimbabwe

CARPHA countries and entities

  1. Antigua and Barbuda
  2. Bahamas
  3. Barbados
  4. Belize
  5. Dominica
  6. Grenada
  7. Guyana
  8. Haiti
  9. Jamaica
  10. Saint Kitts and Nevis
  11. Saint Lucia
  12. Saint Vincent and the Grenadines
  13. Suriname
  14. Trinidad and Tobago
  • Anguilla
  • Aruba
  • British Virgin Islands
  • Bermuda
  • Caribbean Netherlands
  • Cayman Islands
  • Curaçao
  • Montserrat
  • Sint Maarten
  • Turks and Caicos Islands

Non-country entities

  • Cook Islands
  • Falkland Islands
  • French Polynesia
  • Greenland
  • Guadeloupe
  • Guernsey
  • Isle of Man
  • Jersey
  • Northern Cyprus
  • Pitcairn
  • Saint Helena, Ascension and Tristan da Cunha
  • Wallis and Futuna
  • World Health Organization
Travel-only
  • Hong Kong
  • Switzerland
  • United States

EMA countries

  1. Austria
  2. Belgium
  3. Bulgaria
  4. Croatia
  5. Cyprus
  6. Czech Republic
  7. Denmark
  8. Estonia
  9. Finland
  10. France
  11. Germany
  12. Greece
  13. Hungary
  14. Iceland
  15. Ireland
  16. Italy
  17. Latvia
  18. Liechtenstein
  19. Lithuania
  20. Luxembourg
  21. Malta
  22. Netherlands
  23. Norway
  24. Poland
  25. Portugal
  26. Romania
  27. Slovakia
  28. Slovenia
  29. Spain
  30. Sweden

Pfizer–BioNTech

  Full authorization
  Emergency authorization
  Eligible COVAX recipient

The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA vaccine produced by the German company BioNTech and the American company Pfizer. In Hong Kong, Macau, and Taiwan, Comirnaty is distributed by Fosun Pharma.

Original

Full (39)
  1. Australia
  2. Brazil
  3. Canada
  4. Marshall Islands
  5. Micronesia
  6. New Zealand
  7. Palau
  8. Saudi Arabia
  9. Switzerland

EMA countries

  1. Austria
  2. Belgium
  3. Bulgaria
  4. Croatia
  5. Cyprus
  6. Czech Republic
  7. Denmark
  8. Estonia
  9. Finland
  10. France
  11. Germany
  12. Greece
  13. Hungary
  14. Iceland
  15. Ireland
  16. Italy
  17. Latvia
  18. Liechtenstein
  19. Lithuania
  20. Luxembourg
  21. Malta
  22. Netherlands
  23. Norway
  24. Poland
  25. Portugal
  26. Romania
  27. Slovakia
  28. Slovenia
  29. Spain
  30. Sweden

Non-country entities

  • Hong Kong
Emergency (145)
  1. Afghanistan
  2. Albania
  3. Algeria
  4. Andorra
  5. Argentina
  6. Armenia
  7. Azerbaijan
  8. Bahrain
  9. Bangladesh
  10. Benin
  11. Bhutan
  12. Bolivia
  13. Bosnia and Herzegovina
  14. Botswana
  15. Brunei
  16. Cambodia
  17. Cameroon
  18. Cape Verde
  19. Chile
  20. China (For German citizens)
  21. Colombia
  22. Congo-Kinshasa
  23. Costa Rica
  24. Djibouti
  25. Dominican Republic
  26. East Timor
  27. Ecuador
  28. Egypt
  29. El Salvador
  30. Eswatini
  31. Fiji
  32. Gabon
  33. Georgia
  34. Ghana
  35. Guatemala
  36. Guinea
  37. Honduras
  38. Indonesia
  39. Iraq
  40. Israel
  41. Ivory Coast
  42. Japan
  43. Jordan
  44. Kazakhstan
  45. Kenya
  46. Kosovo
  47. Kuwait
  48. Kyrgyzstan
  49. Laos
  50. Lebanon
  51. Libya
  52. Malawi
  53. Malaysia
  54. Maldives
  55. Mexico
  56. Moldova
  57. Monaco
  58. Mongolia
  59. Montenegro
  60. Morocco
  61. Namibia
  62. Nepal
  63. Nicaragua
  64. Nigeria
  65. North Macedonia
  66. Oman
  67. Pakistan
  68. Palestine
  69. Panama
  70. Papua New Guinea
  71. Paraguay
  72. Peru
  73. Philippines
  74. Qatar
  75. Rwanda
  76. Samoa
  77. San Marino
  78. Serbia
  79. Singapore
  80. Somalia
  81. South Africa
  82. South Korea
  83. Sri Lanka
  84. Sudan
  85. Syria
  86. Taiwan
  87. Tajikistan
  88. Tanzania
  89. Thailand
  90. Tonga
  91. Tunisia
  92. Turkey
  93. Uganda
  94. Ukraine
  95. United Arab Emirates
  96. United Kingdom
  97. Uruguay
  98. Uzbekistan
  99. Vatican City
  100. Vietnam
  101. Yemen
  102. Zambia

CARPHA countries and entities

  1. Antigua and Barbuda
  2. Bahamas
  3. Barbados
  4. Belize
  5. Dominica
  6. Grenada
  7. Guyana
  8. Haiti
  9. Jamaica
  10. Saint Kitts and Nevis
  11. Saint Lucia
  12. Saint Vincent and the Grenadines
  13. Suriname
  14. Trinidad and Tobago
  • Anguilla
  • Aruba
  • British Virgin Islands
  • Bermuda
  • Caribbean Netherlands
  • Cayman Islands
  • Curaçao
  • Montserrat
  • Sint Maarten
  • Turks and Caicos Islands


Non-country entities

  • American Samoa
  • Cook Islands
  • Faroe Islands
  • French Polynesia
  • Gibraltar
  • Greenland
  • Guadeloupe
  • Guam
  • Guernsey
  • Isle of Man
  • Jersey
  • Macau
  • Martinique
  • New Caledonia
  • Niue
  • Northern Cyprus
  • Northern Mariana Islands
  • Puerto Rico
  • Tokelau
  • World Health Organization

Bivalent original–BA.1

  1. Japan

EMA countries

  1. Austria
  2. Belgium
  3. Bulgaria
  4. Croatia
  5. Cyprus
  6. Czech Republic
  7. Denmark
  8. Estonia
  9. Finland
  10. France
  11. Germany
  12. Greece
  13. Hungary
  14. Iceland
  15. Ireland
  16. Italy
  17. Latvia
  18. Liechtenstein
  19. Lithuania
  20. Luxembourg
  21. Malta
  22. Netherlands
  23. Norway
  24. Poland
  25. Portugal
  26. Romania
  27. Slovakia
  28. Slovenia
  29. Spain
  30. Sweden

Non-country entities

Bivalent original–BA.4/5

  1. Canada
  2. China (For German citizens)
  3. United States

EMA countries

  1. Austria
  2. Belgium
  3. Bulgaria
  4. Croatia
  5. Cyprus
  6. Czech Republic
  7. Denmark
  8. Estonia
  9. Finland
  10. France
  11. Germany
  12. Greece
  13. Hungary
  14. Iceland
  15. Ireland
  16. Italy
  17. Latvia
  18. Liechtenstein
  19. Lithuania
  20. Luxembourg
  21. Malta
  22. Netherlands
  23. Norway
  24. Poland
  25. Portugal
  26. Romania
  27. Slovakia
  28. Slovenia
  29. Spain
  30. Sweden

Non-country entities

Janssen

  Full authorization
  Full authorization, not used
  Emergency authorization
  Allowed for travel
  Eligible COVAX recipient
  Usage stopped

The Janssen COVID-19 vaccine is a viral vector vaccine produced by Janssen Pharmaceutica (a subsidiary of Johnson & Johnson) and Beth Israel Deaconess Medical Center. It is also known as Johnson & Johnson COVID-19 Vaccine and as COVID-19 Vaccine Janssen. Three countries, Denmark, Finland, and Norway, discontinued the use of the Janssen vaccine in favor of other available vaccines due to a possible link between the vaccine and a rare blood clot disorder. The use of the Janssen adenovirus vector vaccine began in Finland in October 2021. It is only offered for those aged 65 and over because of a very rare risk of thrombosis in younger age groups.

Full (3)
  1. Australia (not used)
  2. Canada
  3. Switzerland
Emergency (133)
  1. Afghanistan
  2. Andorra
  3. Argentina
  4. Bahamas
  5. Bahrain
  6. Bangladesh
  7. Benin
  8. Bolivia
  9. Botswana
  10. Brazil
  11. Brunei
  12. Burkina Faso
  13. Cambodia
  14. Cameroon
  15. Central African Republic
  16. Chile
  17. Colombia
  18. Congo-Kinshasa
  19. Djibouti
  20. Egypt
  21. Eswatini
  22. Ethiopia
  23. Gabon
  24. Ghana
  25. Guinea
  26. Honduras
  27. India
  28. Indonesia
  29. Iran
  30. Iraq
  31. Ivory Coast
  32. Jordan
  33. Kenya
  34. Kuwait
  35. Laos
  36. Lebanon
  37. Lesotho
  38. Liberia
  39. Libya
  40. Madagascar
  41. Malawi
  42. Malaysia
  43. Maldives
  44. Mali
  45. Marshall Islands
  46. Mauritania
  47. Mexico
  48. Micronesia
  49. Moldova
  50. Monaco
  51. Morocco
  52. Mozambique
  53. Namibia
  54. Nepal
  55. New Zealand
  56. Nicaragua
  57. Nigeria
  58. Oman
  59. Pakistan
  60. Palau
  61. Palestine
  62. Papua New Guinea
  63. Peru
  64. Philippines
  65. Qatar
  66. Rwanda
  67. Saudi Arabia
  68. Senegal
  69. Singapore(restricted)
  70. Somalia
  71. South Africa
  72. South Korea
  73. South Sudan
  74. Sudan
  75. Syria
  76. Taiwan (not used)
  77. Tanzania
  78. Thailand
  79. Tunisia
  80. Uganda
  81. Ukraine
  82. United Arab Emirates
  83. United Kingdom
  84. United States
  85. Vanuatu
  86. Vietnam
  87. Yemen
  88. Zambia
  89. Zimbabwe

EMA countries

  1. Austria
  2. Belgium
  3. Bulgaria
  4. Croatia
  5. Cyprus
  6. Czech Republic
  7. Denmark
  8. Estonia
  9. Finland
  10. France
  11. Germany
  12. Greece
  13. Hungary
  14. Iceland
  15. Ireland
  16. Italy
  17. Latvia
  18. Liechtenstein
  19. Lithuania
  20. Luxembourg
  21. Malta
  22. Netherlands
  23. Norway
  24. Poland
  25. Portugal
  26. Romania
  27. Slovakia
  28. Slovenia
  29. Spain
  30. Sweden

CARPHA countries and entities

  1. Antigua and Barbuda
  2. Bahamas
  3. Barbados
  4. Belize
  5. Dominica
  6. Grenada
  7. Guyana
  8. Haiti
  9. Jamaica
  10. Saint Kitts and Nevis
  11. Saint Lucia
  12. Saint Vincent and the Grenadines
  13. Suriname
  14. Trinidad and Tobago
  • Anguilla
  • Aruba
  • British Virgin Islands
  • Bermuda
  • Caribbean Netherlands
  • Cayman Islands
  • Curaçao
  • Montserrat
  • Sint Maarten
  • Turks and Caicos Islands

Non-country entities

  • American Samoa
  • French Polynesia
  • Greenland
  • Guam
  • New Caledonia
  • Northern Cyprus
  • Northern Mariana Islands
  • Puerto Rico
  • Africa Regulatory Taskforce
  • World Health Organization
Travel-only
  • Hong Kong
  • Japan
  • Turkey

Moderna

  Full authorization
  Emergency authorization
  Allowed for travel
  Eligible COVAX recipient

The Moderna COVID-19 vaccine, also known as Spikevax, is an mRNA vaccine produced by the American company Moderna, the U.S. National Institute of Allergy and Infectious Diseases, the U.S. Biomedical Advanced Research and Development Authority, and the Coalition for Epidemic Preparedness Innovations. The Moderna vaccine is not offered for men under 30 years of age in Finland as a precaution to reduce a very rare risk of myocarditis.

Original

Full (34)
  1. Australia
  2. Canada
  3. Switzerland
  4. United Kingdom

EMA countries

  1. Austria
  2. Belgium
  3. Bulgaria
  4. Croatia
  5. Cyprus
  6. Czech Republic
  7. Denmark
  8. Estonia
  9. Finland
  10. France
  11. Germany
  12. Greece
  13. Hungary
  14. Iceland
  15. Ireland
  16. Italy
  17. Latvia
  18. Liechtenstein
  19. Lithuania
  20. Luxembourg
  21. Malta
  22. Netherlands
  23. Norway
  24. Poland
  25. Portugal
  26. Romania
  27. Slovakia
  28. Slovenia
  29. Spain
  30. Sweden
Emergency (116)
  1. Andorra
  2. Argentina
  3. Armenia
  4. Bahrain
  5. Bangladesh
  6. Bhutan
  7. Botswana
  8. Bolivia
  9. Brazil
  10. Brunei
  11. Cape Verde
  12. Chile
  13. Colombia
  14. Congo-Brazzaville
  15. Congo-Kinshasa
  16. Djibouti
  17. Egypt
  18. El Salvador
  19. Fiji
  20. Ghana
  21. Guatemala
  22. Honduras
  23. India
  24. Indonesia
  25. Iran
  26. Iraq
  27. Israel
  28. Japan
  29. Jordan
  30. Kenya
  31. Kuwait
  32. Kyrgyzstan
  33. Lebanon
  34. Libya
  35. Malawi
  36. Malaysia
  37. Maldives
  38. Marshall Islands
  39. Mexico
  40. Micronesia
  41. Moldova
  42. Monaco
  43. Mongolia
  44. Morocco
  45. Nepal
  46. Nigeria
  47. Oman
  48. Pakistan
  49. Palau
  50. Palestine
  51. Paraguay
  52. Peru
  53. Philippines
  54. Qatar
  55. Rwanda
  56. Saudi Arabia
  57. Serbia
  58. Singapore
  59. South Korea
  60. Sri Lanka
  61. Sudan
  62. Syria
  63. Taiwan
  64. Tajikistan
  65. Thailand
  66. Tunisia
  67. Uganda
  68. Ukraine
  69. United Arab Emirates
  70. Uzbekistan
  71. Vietnam
  72. Yemen

CARPHA countries and entities

  1. Antigua and Barbuda
  2. Bahamas
  3. Barbados
  4. Belize
  5. Dominica
  6. Grenada
  7. Guyana
  8. Haiti
  9. Jamaica
  10. Saint Kitts and Nevis
  11. Saint Lucia
  12. Saint Vincent and the Grenadines
  13. Suriname
  14. Trinidad and Tobago
  • Anguilla
  • Aruba
  • British Virgin Islands
  • Bermuda
  • Caribbean Netherlands
  • Cayman Islands
  • Curaçao
  • Montserrat
  • Sint Maarten
  • Turks and Caicos Islands


Non-country entities

  • American Samoa
  • Faroe Islands
  • Greenland
  • Guadeloupe
  • Guam
  • Guernsey
  • Isle of Man
  • Jersey
  • Northern Mariana Islands
  • Puerto Rico
  • Wallis and Futuna
  • World Health Organization
Travel-only
  • Hong Kong
  • New Zealand
  • Turkey

Bivalent original–BA.1

  1. Australia
  2. Canada
  3. Japan
  4. Singapore
  5. Switzerland
  6. Taiwan
  7. United Kingdom

EMA countries

  1. Austria
  2. Belgium
  3. Bulgaria
  4. Croatia
  5. Cyprus
  6. Czech Republic
  7. Denmark
  8. Estonia
  9. Finland
  10. France
  11. Germany
  12. Greece
  13. Hungary
  14. Iceland
  15. Ireland
  16. Italy
  17. Latvia
  18. Liechtenstein
  19. Lithuania
  20. Luxembourg
  21. Malta
  22. Netherlands
  23. Norway
  24. Poland
  25. Portugal
  26. Romania
  27. Slovakia
  28. Slovenia
  29. Spain
  30. Sweden

Bivalent original–BA.4/5

  1. Taiwan
  2. United States

Sinopharm BIBP

  Full authorization
  Emergency authorization
  Allowed for travel
  Eligible COVAX recipient

The Sinopharm BIBP COVID-19 vaccine is an inactivated virus vaccine produced by the China National Pharmaceutical Group (Sinopharm) and its Beijing Institute of Biological Products.

Full (4)
  1. Bahrain
  2. China
  3. Seychelles
  4. United Arab Emirates
Emergency (111)
  1. Afghanistan
  2. Algeria
  3. Angola
  4. Argentina
  5. Armenia
  6. Bangladesh
  7. Belarus
  8. Bhutan
  9. Bolivia
  10. Bosnia and Herzegovina
  11. Brazil
  12. Brunei
  13. Burkina Faso
  14. Burundi
  15. Cambodia
  16. Cameroon
  17. Cape Verde
  18. Chad
  19. Comoros
  20. Congo-Brazzaville
  21. Cuba
  22. Djibouti
  23. Dominican Republic
  24. Egypt
  25. El Salvador
  26. Equatorial Guinea
  27. Ethiopia
  28. Gabon
  29. Gambia
  30. Georgia
  31. Guinea-Bissau
  32. Guinea
  33. Hungary
  34. Indonesia
  35. Iran
  36. Iraq
  37. Ivory Coast
  38. Jordan
  39. Kazakhstan
  40. Kenya
  41. Kiribati
  42. Kuwait
  43. Kyrgyzstan
  44. Laos
  45. Lebanon
  46. Lesotho
  47. Libya
  48. Madagascar
  49. Malawi
  50. Malaysia
  51. Maldives
  52. Mauritania
  53. Mauritius
  54. Mexico
  55. Moldova
  56. Mongolia
  57. Montenegro
  58. Morocco
  59. Mozambique
  60. Myanmar
  61. Namibia
  62. Nepal
  63. Nicaragua
  64. Niger
  65. Nigeria
  66. North Korea
  67. North Macedonia
  68. Oman
  69. Pakistan
  70. Palestine
  71. Papua New Guinea
  72. Paraguay
  73. Peru
  74. Philippines
  75. Qatar
  76. Rwanda
  77. Senegal
  78. Serbia
  79. Sierra Leone
  80. Singapore
  81. Solomon Islands
  82. Somalia
  83. South Sudan
  84. Sri Lanka
  85. Sudan
  86. Syria
  87. Tanzania
  88. Thailand
  89. Tunisia
  90. Turkmenistan
  91. Vanuatu
  92. Venezuela
  93. Vietnam
  94. Yemen
  95. Zambia
  96. Zimbabwe

CARPHA countries and entities

  1. Antigua and Barbuda
  2. Bahamas
  3. Barbados
  4. Belize
  5. Dominica
  6. Grenada
  7. Guyana
  8. Haiti
  9. Jamaica
  10. Saint Kitts and Nevis
  11. Saint Lucia
  12. Saint Vincent and the Grenadines
  13. Suriname
  14. Trinidad and Tobago
  • Anguilla
  • Aruba
  • British Virgin Islands
  • Bermuda
  • Caribbean Netherlands
  • Cayman Islands
  • Curaçao
  • Montserrat
  • Sint Maarten
  • Turks and Caicos Islands


Non-country entities

Travel-only
  • Andorra
  • Australia
  • Austria (only for entry)
  • Bulgaria
  • Canada
  • Chile
  • Costa Rica
  • Croatia
  • Cyprus
  • Czech Republic (only for Hungarian citizens and EU nationals vaccinated in Hungary)
  • Estonia (only if approved in a person's country of origin)
  • Finland
  • Greece
  • Grenada
  • Hong Kong
  • Iceland
  • Ireland
  • Japan
  • Latvia
  • Liechtenstein
  • New Zealand
  • Oman
  • Panama
  • Portugal (only in Madeira)
  • Qatar
  • Saudi Arabia (for short visits, Hajj and Umrah only)
  • Slovakia
  • Slovenia
  • South Korea
  • Spain
  • St. Kitts and Nevis
  • St. Lucia
  • St. Vincent and the Grenadines
  • Sweden
  • Switzerland
  • The Netherlands
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Uruguay (only if approved in a person's country of origin)

Sputnik V

  Full authorization
  Emergency authorization
  Authorization expired
  Allowed for travel
  Rejected

The Sputnik V COVID-19 vaccine is a viral vector vaccine produced by the Russian Gamaleya Research Institute of Epidemiology and Microbiology.

Full (3)
  1. Russia
  2. Turkmenistan
  3. Uzbekistan
Emergency (76)
  1. Albania
  2. Algeria
  3. Angola
  4. Antigua and Barbuda
  5. Argentina
  6. Armenia
  7. Azerbaijan
  8. Bahrain
  9. Bangladesh
  10. Belarus
  11. Bolivia
  12. Bosnia and Herzegovina
  13. Brazil(restricted)
  14. Cambodia
  15. Cameroon
  16. Chile
  17. Congo-Brazzaville
  18. Djibouti
  19. Ecuador
  20. Egypt
  21. Gabon
  22. Gambia
  23. Ghana
  24. Guatemala
  25. Guinea
  26. Guyana
  27. Honduras
  28. Hungary
  29. India
  30. Indonesia
  31. Iran
  32. Iraq
  33. Ivory Coast
  34. Jordan
  35. Kazakhstan
  36. Kenya
  37. Kyrgyzstan
  38. Laos
  39. Lebanon
  40. Libya
  41. Maldives
  42. Mali
  43. Mauritius
  44. Mexico
  45. Moldova
  46. Mongolia
  47. Montenegro
  48. Morocco
  49. Myanmar
  50. Namibia
  51. Nepal
  52. Nicaragua
  53. Nigeria
  54. North Macedonia
  55. Oman
  56. Pakistan
  57. Palestine
  58. Panama
  59. Paraguay
  60. Peru
  61. Philippines
  62. Rwanda
  63. Saint Vincent and the Grenadines
  64. San Marino
  65. Serbia
  66. Seychelles
  67. Sri Lanka
  68. Syria
  69. Tajikistan
  70. Tanzania
  71. Tunisia
  72. Turkey (limited use)
  73. United Arab Emirates
  74. Venezuela
  75. Vietnam
  76. Zimbabwe


Non-country entities

  • Abkhazia
  • South Ossetia


Expired
  • Slovakia
Rejected
  • South Africa
Travel-only
  • Australia
  • Cyprus
  • Estonia
  • Greece
  • Hong Kong
  • Israel
  • Malaysia
  • New Zealand
  • Saudi Arabia
  • Slovenia
  • St. Lucia
  • Thailand

CoronaVac

  Full authorization
  Emergency authorization
  Allowed for travel
  Eligible COVAX recipient

The CoronaVac COVID-19 vaccine is an inactivated virus vaccine produced by the Chinese company Sinovac Biotech.

Full (1)
  1. China


Non-country entities

  • Hong Kong
Emergency (71)
  1. Afghanistan
  2. Albania
  3. Algeria
  4. Argentina
  5. Armenia
  6. Azerbaijan
  7. Bangladesh
  8. Benin
  9. Bolivia
  10. Bosnia and Herzegovina
  11. Botswana
  12. Brazil
  13. Cambodia
  14. Chile
  15. Colombia
  16. Djibouti
  17. Dominica
  18. Dominican Republic
  19. East Timor
  20. Ecuador
  21. Egypt
  22. El Salvador
  23. Equatorial Guinea
  24. Fiji
  25. Gabon
  26. Georgia
  27. Guinea
  28. Guyana
  29. Hungary
  30. Indonesia
  31. Iraq
  32. Jordan
  33. Kazakhstan
  34. Kuwait
  35. Laos
  36. Lebanon
  37. Libya
  38. Malawi
  39. Malaysia
  40. Maldives
  41. Mexico
  42. Moldova
  43. Morocco
  44. Myanmar
  45. Nepal
  46. North Macedonia
  47. Oman
  48. Pakistan
  49. Palestine
  50. Panama
  51. Paraguay
  52. Philippines
  53. Qatar
  54. Rwanda
  55. Saint Vincent and the Grenadines
  56. Saudi Arabia
  57. Singapore
  58. Somalia
  59. South Africa
  60. Sri Lanka
  61. Sudan
  62. Syria
  63. Tajikistan
  64. Tanzania
  65. Thailand
  66. Togo
  67. Trinidad and Tobago
  68. Tunisia
  69. Turkey
  70. Turkmenistan
  71. Uganda
  72. Ukraine
  73. United Arab Emirates
  74. Uruguay
  75. Uzbekistan
  76. Venezuela
  77. Yemen
  78. Zimbabwe


Non-country entities

Travel-only
  • Andorra
  • Australia
  • Austria (only for entry)
  • Canada
  • Costa Rica
  • Croatia
  • Cyprus
  • Estonia (only if approved in a person's country of origin)
  • Finland
  • Greece
  • Grenada
  • Iceland
  • Ireland
  • Japan
  • Liechtenstein
  • Norway
  • New Zealand
  • Norway
  • Palau
  • Panama
  • Portugal (only in Madeira)
  • Slovakia
  • Slovenia
  • South Korea
  • Spain
  • St. Kitts and Nevis
  • St. Lucia
  • St. Vincent and the Grenadines
  • Sweden
  • Switzerland
  • The Netherlands
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • Vietnam

Novavax

  Full authorization
  Emergency authorization
  Allowed for travel
  Eligible COVAX recipient

The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, is a subunit COVID-19 vaccine candidate developed by Novavax and the Coalition for Epidemic Preparedness Innovations.

Full (4)
  1. Australia
  2. Canada
  3. Japan
  4. South Korea
Emergency (57)
  1. Bangladesh
  2. India
  3. Indonesia
  4. Monaco
  5. New Zealand
  6. Philippines
  7. Singapore
  8. South Africa
  9. Switzerland
  10. Thailand
  11. Taiwan
  12. United Kingdom
  13. United States

EMA countries

  1. Austria
  2. Belgium
  3. Bulgaria
  4. Croatia
  5. Cyprus
  6. Czech Republic
  7. Denmark
  8. Estonia
  9. Finland
  10. France
  11. Germany
  12. Greece
  13. Hungary
  14. Iceland
  15. Ireland
  16. Italy
  17. Latvia
  18. Liechtenstein
  19. Lithuania
  20. Luxembourg
  21. Malta
  22. Netherlands
  23. Norway
  24. Poland
  25. Portugal
  26. Romania
  27. Slovakia
  28. Slovenia
  29. Spain
  30. Sweden

CARPHA countries and entities

  1. Antigua and Barbuda
  2. Bahamas
  3. Barbados
  4. Belize
  5. Dominica
  6. Grenada
  7. Guyana
  8. Haiti
  9. Jamaica
  10. Saint Kitts and Nevis
  11. Saint Lucia
  12. Saint Vincent and the Grenadines
  13. Suriname
  14. Trinidad and Tobago
  • Anguilla
  • Aruba
  • British Virgin Islands
  • Bermuda
  • Caribbean Netherlands
  • Cayman Islands
  • Curaçao
  • Montserrat
  • Sint Maarten
  • Turks and Caicos Islands


Non-country entities

Travel-only
  • Hong Kong
  • Palau
  • Panama
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United States

Covaxin

  Full authorization
  Emergency authorization
  Allowed for travel
  Eligible COVAX recipient

Covaxin is an inactivated virus vaccine produced by the Indian company Bharat Biotech in collaboration with the Indian Council of Medical Research–National Institute of Virology.

Full (1)
  1. India
Emergency (50)
  1. Afghanistan
  2. Bahrain
  3. Botswana
  4. Central African Republic
  5. Comoros
  6. Egypt
  7. Ethiopia
  8. Guatemala (not used)
  9. Iran
  10. Iraq
  11. Jordan
  12. Kuwait
  13. Lebanon
  14. Libya
  15. Malaysia
  16. Mauritius
  17. Mexico (not used)
  18. Morocco
  19. Myanmar
  20. Nepal
  21. Nicaragua (not used)
  22. Oman
  23. Pakistan
  24. Paraguay
  25. Philippines
  26. Qatar
  27. Somalia
  28. Sudan
  29. Syria
  30. Tunisia
  31. United Arab Emirates
  32. Venezuela (not used)
  33. Vietnam
  34. Yemen
  35. Zimbabwe

CARPHA countries and entities

  1. Antigua and Barbuda
  2. Bahamas
  3. Barbados
  4. Belize
  5. Dominica
  6. Grenada
  7. Guyana (not used)
  8. Haiti
  9. Jamaica
  10. Saint Kitts and Nevis
  11. Saint Lucia
  12. Saint Vincent and the Grenadines
  13. Suriname
  14. Trinidad and Tobago
  • Anguilla
  • Aruba
  • British Virgin Islands
  • Bermuda
  • Caribbean Netherlands
  • Cayman Islands
  • Curaçao
  • Montserrat
  • Sint Maarten
  • Turks and Caicos Islands


Non-country entities

Travel-only
  • Andorra
  • Australia
  • Austria (only for entry)
  • Canada
  • Costa Rica
  • Croatia
  • Cyprus
  • Estonia (only if approved in a person's country of origin)
  • Finland
  • Greece
  • Hong Kong
  • Iceland
  • Ireland
  • Japan
  • Kyrgyzstan
  • Liechtenstein
  • Mongolia
  • New Zealand
  • Norway
  • Oman
  • Palestine
  • Palau
  • Panama
  • Portugal (only in Madeira)
  • Saudi Arabia
  • Singapore
  • Slovakia
  • Slovenia
  • South Korea
  • Spain
  • Sri Lanka
  • Sweden
  • Switzerland
  • Thailand
  • The Netherlands
  • Turkey
  • Ukraine
  • United Kingdom
  • United States

VLA2001

  Full authorization
  Emergency authorization
  Allowed for travel

VLA2001 is an inactivated vaccine developed by Valneva SE and Dynavax Technologies.

Full (1)
  1. United Kingdom
Emergency (32)
  1. Bahrain
  2. United Arab Emirates

EMA countries

  1. Austria
  2. Belgium
  3. Bulgaria
  4. Croatia
  5. Cyprus
  6. Czech Republic
  7. Denmark
  8. Estonia
  9. Finland
  10. France
  11. Germany
  12. Greece
  13. Hungary
  14. Iceland
  15. Ireland
  16. Italy
  17. Latvia
  18. Liechtenstein
  19. Lithuania
  20. Luxembourg
  21. Malta
  22. Netherlands
  23. Norway
  24. Poland
  25. Portugal
  26. Romania
  27. Slovakia
  28. Slovenia
  29. Spain
  30. Sweden
Travel-only
  • Malaysia
  • New Zealand
  • Turkey

Sanofi–GSK

The Sanofi–GSK COVID-19 vaccine, sold under the brand name VidPrevtyn Beta, is a subunit vaccine developed by Sanofi Pasteur and GSK plc. It is based on the SARS-CoV-2 Beta variant.

EMA countries (as booster only)

  1. Austria
  2. Belgium
  3. Bulgaria
  4. Croatia
  5. Cyprus
  6. Czech Republic
  7. Denmark
  8. Estonia
  9. Finland
  10. France
  11. Germany
  12. Greece
  13. Hungary
  14. Iceland
  15. Ireland
  16. Italy
  17. Latvia
  18. Liechtenstein
  19. Lithuania
  20. Luxembourg
  21. Malta
  22. Netherlands
  23. Norway
  24. Poland
  25. Portugal
  26. Romania
  27. Slovakia
  28. Slovenia
  29. Spain
  30. Sweden

Sputnik Light

  Full authorization
  Emergency authorization
  Allowed for travel

Sputnik Light is a viral vector vaccine, produced by the Russian Gamaleya Research Institute of Epidemiology and Microbiology. It consists of the first dose of the Sputnik V vaccine, which is based on the Ad26 vector.

Full (0)
Emergency (28)
  1. Angola
  2. Argentina
  3. Armenia
  4. Bahrain
  5. Belarus
  6. Benin
  7. Cambodia
  8. Congo-Brazzaville
  9. Egypt
  10. Iran
  11. India
  12. Kazakhstan
  13. Kyrgyzstan
  14. Laos
  15. Mauritius
  16. Mongolia
  17. Nicaragua
  18. Palestine
  19. Philippines
  20. Russia
  21. Saint Vincent and the Grenadines
  22. San Marino
  23. Syria
  24. Tanzania
  25. Tunisia
  26. Turkmenistan
  27. United Arab Emirates
  28. Venezuela


Non-country entities

  • Abkhazia
  • Donbass Region (unofficially)
Travel-only
  • Malaysia
  • New Zealand
  • Turkey

Convidecia

  Full authorization
  Emergency authorization
  Allowed for travel

Convidecia is a viral vector vaccine produced by the Chinese company CanSino Biologics and the Beijing Institute of Biotechnology of the Academy of Military Medical Sciences.

Full (1)
  1. China
Emergency (9)
  1. Argentina
  2. Chile
  3. Ecuador
  4. Hungary
  5. Indonesia
  6. Malaysia
  7. Mexico
  8. Moldova
  9. Pakistan


Non-country entities

Travel-only
  • Hong Kong
  • Japan
  • New Zealand
  • Turkey

Sinopharm WIBP

  Full authorization
  Emergency authorization
  Allowed for travel

The Sinopharm WIBP COVID-19 vaccine is an inactivated virus vaccine produced by the China National Pharmaceutical Group (Sinopharm) and its Wuhan Institute of Biological Products.

Full (1)
  1. China
Emergency (5)
  1. Armenia
  2. North Macedonia
  3. Peru
  4. Philippines
  5. United Arab Emirates
  6. Venezuela
Travel-only
  • Hong Kong
  • Malaysia
  • New Zealand
  • Turkey

Abdala

  Full authorization
  Emergency authorization
  Allowed for travel

Abdala is a subunit vaccine developed by the Center for Genetic Engineering and Biotechnology in Cuba.

Full (0)
Emergency (6)
  1. Cuba
  2. Mexico
  3. Nicaragua
  4. St. Vincent and the Grenadines
  5. Venezuela
  6. Vietnam
Travel-only
  • Cambodia
  • Colombia
  • Guyana
  • Malaysia
  • New Zealand
  • St. Lucia
  • Turkey
  • Uruguay (only if accepted in the country of the person's origin)

EpiVacCorona

  Full authorization
  Emergency authorization
  Allowed for travel

EpiVacCorona is a peptide vaccine produced by the Russian State Research Center of Virology and Biotechnology VECTOR.

Full (1)
  1. Turkmenistan
Emergency (4)
  1. Belarus
  2. Cambodia
  3. Russia
  4. Venezuela
Travel-only
  • Malaysia
  • New Zealand
  • Turkey

Zifivax

  Full authorization
  Emergency authorization
  Allowed for travel

Zifivax is a subunit vaccine produced by the Chinese company Anhui Zhifei Longcom Biopharmaceutical.

Full (0)
Emergency (5)
  1. China
  2. Colombia
  3. Indonesia
  4. Pakistan
  5. Uzbekistan
Travel-only
  • Hong Kong
  • Malaysia
  • New Zealand
  • Turkey

Soberana 02

  Full authorization
  Emergency authorization
  Allowed for travel

Soberana 02, is a conjugate vaccine developed by the Finlay Institute in Cuba.

Full (0)
Emergency (4)
  1. Cuba
  2. Iran
  3. Nicaragua
  4. Venezuela
Travel-only
  • Guyana
  • Hungary
  • Malaysia
  • New Zealand
  • Turkey

CoviVac

  Full authorization
  Emergency authorization
  Allowed for travel

CoviVac is an inactivated virus vaccine produced by the Chumakov Centre at the Russian Academy of Sciences.

Full (0)
Emergency (3)
  1. Belarus
  2. Cambodia
  3. Russia
Travel-only
  • Malaysia
  • New Zealand
  • Turkey

QazCovid-in

  Full authorization
  Emergency authorization
  Allowed for travel

QazCovid-in, also known as QazVac, is an inactivated virus vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan.

Full (0)
Emergency (2)
  1. Kazakhstan
  2. Kyrgyzstan
Travel-only
  • Malaysia
  • New Zealand
  • Turkey

Minhai

  Full authorization
  Emergency authorization
  Allowed for travel

Minhai COVID-19 vaccine, is an inactivated virus vaccine developed by Minhai Biotechnology Co. and Shenzhen Kangtai Biological Products Co. Ltd. in China.

Full (0)
Emergency (2)
  1. China
  2. Indonesia
Travel-only
  • Hong Kong
  • Malaysia
  • New Zealand
  • Turkey

Medigen

  Full authorization
  Emergency authorization
  Allowed for travel

MVC-COV1901, is a protein subunit vaccine developed by Taiwan's Medigen Vaccine Biologics and Dynavax Technologies.

Full (0)
Emergency (3)
  1. Eswatini
  2. Taiwan
  3. Paraguay
Non-country entities

1. Somaliland

Travel-only
  • Belize
  • Indonesia
  • Malaysia
  • New Zealand
  • Palau
  • Thailand
  • Turkey

Corbevax

Corbevax is a protein subunit vaccine developed by Texas Children's Hospital at the Baylor College of Medicine in Houston, Texas, and licensed to Indian biopharmaceutical firm Biological E. Limited (BioE) for development and production.

Full (0)
Emergency (2)
  1. India
  2. Botswana
Travel-only
  • Malaysia
  • New Zealand
  • Turkey

COVIran Barekat

COVIran Barekat, is an inactivated virus vaccine developed by Shifa Pharmed Industrial Co. in Iran.

Full (0)
Emergency (2)
  1. Iran
  2. Nicaragua
Travel-only
  • Malaysia
  • New Zealand
  • Hungary
  • Turkey

Chinese Academy of Medical Sciences

Chinese Academy of Medical Sciences COVID-19 vaccine, is an inactivated virus vaccine developed by Chinese Academy of Medical Sciences.

Full (0)
Emergency (1)
  1. China
Travel-only
  • Hong Kong
  • New Zealand
  • Turkey

ZyCoV-D

ZyCoV-D, is a DNA plasmid based COVID-19 vaccine developed by the Indian pharmaceutical company Cadila Healthcare with support from the Biotechnology Industry Research Assistance Council.

Full (0)
Emergency (1)
  1. India
Travel-only
  • Malaysia
  • New Zealand
  • Turkey

FAKHRAVAC

FAKHRAVAC (or MIVAC), is an inactivated virus vaccine developed in Iran by the Organization of Defensive Innovation and Research, an organization of Iran's Ministry of Defense.

Full (0)
Emergency (1)
  1. Iran
Travel-only
  • Hungary
  • Malaysia
  • New Zealand
  • Turkey

COVAX-19

COVAX-19, also known as SpikoGen, is a protein subunit vaccine jointly developed by Australian-based company Vaxine and Iran-based company CinnaGen.

Full (0)
Emergency (1)
  1. Iran
Travel-only
  • Hungary
  • Malaysia
  • New Zealand
  • Turkey

Razi Cov Pars

Razi Cov Pars is a protein subunit vaccine developed by Razi Vaccine and Serum Research Institute.

Full (0)
Emergency (1)
  1. Iran
Travel-only
  • Hungary
  • Malaysia
  • New Zealand
  • Turkey

Turkovac

Turkovac is an inactivated vaccine developed by Health Institutes of Turkey and Erciyes University.

Full (0)
Emergency (1)
  1. Turkey
Travel-only
  • Malaysia
  • New Zealand

Sinopharm CNBG

Sinopharm CNBG COVID-19 vaccine (NVSI) is a recombinant protein subunit vaccine developed by the National Vaccine & Serum Institute (NVSI, 中生研究院), a subsidiary of China National Biotec Group (CNBG), which in turn is a subsidiary of Sinopharm.

Full (0)
Emergency (1)
  1. United Arab Emirates
Travel-only
  • Malaysia
  • Turkey

Soberana Plus

Soberana Plus is a single-dose of conjugate vaccine developed by the Finlay Institute in Cuba.

Full (0)
Emergency (2)
  1. Belarus
  2. Cuba
Travel-only
  • Guyana
  • Malaysia
  • New Zealand
  • Turkey

CoVLP

CoVLP is a virus-like particle vaccine grown in an Australian weed, Nicotiana benthamiana. It was developed by Medicago, and is marketed under the name Covifenz.

Full (1)
  1. Canada
Emergency (0)
Travel-only
  • Malaysia
  • New Zealand
  • Turkey

Noora

Noora is a protein-based vaccine developed by the Baqiyatallah University of Medical Sciences.

Full (0)
Emergency (1)
  1. Iran
Travel-only
  • Malaysia
  • Turkey

SKYCovione

SKYCovione is a protein subunit vaccine developed by SK Bioscience.

Full (0)
Emergency (1)
  1. South Korea

Walvax

Walvax COVID-19 vaccine is an RNA vaccine developed by Walvax Biotechnology, Suzhou Abogen Biosciences, and the PLA Academy of Military Science.

Full (0)
Emergency (1)
  1. Indonesia

iNCOVACC

iNCOVACC, also called BBV154 is an adenovirus vector vaccine developed by Bharat Biotech, Precision Virologics, and Washington University School of Medicine.

Full (0)
Emergency (1)
  1. India

Gemcovac

Gemcovac, or GEMCOVAC-19, is a self-amplifying mRNA vaccine manufactured by Gennova Biopharmaceuticals.

Full (0)
Emergency (1)
  1. India

V-01

V-01 is a protein subunit vaccine developed by Livzon Mabpharm.

Full (0)
Emergency (1)
  1. China

IndoVac

IndoVac is a protein subunit vaccine developed by Indonesian pharmaceutical company Bio Farma and Baylor College of Medicine.

Full (0)
Emergency (1)
  1. Indonesia

Новое сообщение